The DAX 40 experienced positive momentum, rising 0.6% to exceed 25,100, approaching levels last seen in mid-January. Defense stocks provided significant support, while global markets showed signs of stabilization amidst developments in artificial intelligence. Conversely, Bayer faced downward pressure due to legal concerns.
- DAX 40 rose 0.6% to surpass 25,100, trading near the highest level since mid-January.
- Defense stocks, particularly Renk (up 3%) and Rheinmetall (up 1.7%), provided key support.
- Berlin is considering a minority stake in KNDS, the Franco-German maker of Leopard tanks.
- Geopolitical developments, including US-Iran talks in Geneva, remain in focus.
- Global markets appear to be stabilizing after recent turmoil tied to developments in artificial intelligence.
- Bayer declined (-7.5%) due to its Monsanto Unit’s proposed $7.25 billion settlement for Roundup lawsuits.
The DAX’s performance reflects a combination of sector-specific boosts and broader market sentiment. The gains in defense stocks indicate investor confidence in that industry, potentially driven by geopolitical factors. The stabilization of global markets suggests a recovery from recent uncertainties. However, the decline of Bayer demonstrates the potential negative impact of legal liabilities on individual companies within the index.